<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2d1 20170631//EN" "JATS-journalpublishing1.dtd">
<article xlink="http://www.w3.org/1999/xlink" dtd-version="1.0" article-type="healthcare" lang="en"><front><journal-meta><journal-id journal-id-type="publisher">IJCRR</journal-id><journal-id journal-id-type="nlm-ta">I Journ Cur Res Re</journal-id><journal-title-group><journal-title>International Journal of Current Research and Review</journal-title><abbrev-journal-title abbrev-type="pubmed">I Journ Cur Res Re</abbrev-journal-title></journal-title-group><issn pub-type="ppub">2231-2196</issn><issn pub-type="opub">0975-5241</issn><publisher><publisher-name>Radiance Research Academy</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">4591</article-id><article-id pub-id-type="doi"/><article-id pub-id-type="doi-url">https://doi.org/10.31782/IJCRR.2022.141701</article-id><article-categories><subj-group subj-group-type="heading"><subject>Healthcare</subject></subj-group></article-categories><title-group><article-title>&#13;
	Formulation and Evaluation of Euterpeoleracea In-Situ Gel for Better Treatment of Conjunctivitis&#13;
&#13;
&#13;
&#13;
	 &#13;
&#13;
&#13;
&#13;
	 &#13;
&#13;
&#13;
&#13;
	 &#13;
&#13;
</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Spandana</surname><given-names>Kanuri</given-names></name></contrib><contrib contrib-type="author"><name><surname>Kiran</surname><given-names>Ramineni Shireesh</given-names></name></contrib><contrib contrib-type="author"><name><surname>Sharma</surname><given-names>Ganti Subrahmanya</given-names></name></contrib><contrib contrib-type="author"><name><surname>Rao</surname><given-names>Tadikonda Rama</given-names></name></contrib></contrib-group><pub-date pub-type="ppub"><day>6</day><month>09</month><year>2022</year></pub-date><volume>7)</volume><issue/><fpage>1</fpage><lpage>6</lpage><permissions><copyright-statement>This article is copyright of Popeye Publishing, 2009</copyright-statement><copyright-year>2009</copyright-year><license license-type="open-access" href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution (CC BY 4.0) Licence. You may share and adapt the material, but must give appropriate credit to the source, provide a link to the licence, and indicate if changes were made.</license-p></license></permissions><abstract><p>&#13;
	Introduction: This study is to formulate the Euterpe Oleracea in-situ gel for better treatment of conjunctivitis. The Euterpe Oleracea ophthalmic drug solution can treat the ocular infections effectively.&#13;
	Aim: Formulation and evaluation of Eutepe Oleracea in-situ gel for better treatment of conjunctivitis&#13;
	Methodology: Euterpe Oleracea drug containing in-situ gel prepared by using different polymers like carbopol-940, HPMC K15, HPMC K100, HPMC K4M, as a pH triggered gelling system, these polymers are used to controlled release to increase bioavailability.&#13;
	Result: After the formulation prepared it will undergo evaluation i.e. visual appearance, pH, clarity checking, gel capacity, drug content and rheological studies, in-vitro drug release studies, sterility testing were determined. The prepared in situ gel was clear and transparent, it is having good gelling capacity.&#13;
	Conclusion: The drug content of these formulations was determined to be 98%. Developed formulation was stable, and non-irritant, effective therapeutically it can be release in the form of sustained release.&#13;
&#13;
</p></abstract><kwd-group><kwd>Euterpe Oleracea</kwd><kwd> HPMC</kwd><kwd> Citric acid</kwd><kwd> Disodium hydrogen phosphate</kwd><kwd> Tween-80</kwd><kwd> Benzalkonium chloride</kwd></kwd-group></article-meta></front></article>
